What is the CVSS score of CVE-2023-25438?

CVE-2023-25438 has a CVSS 3.1 base score of 7.8 (High). CVSS vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 2.1%.

Is there a public PoC exploit available for CVE-2023-25438?

Yes, a public proof-of-concept exploit is available for CVE-2023-25438. Prioritise patching immediately. EPSS: 2.1%.

Millegpg CVE-2023-25438

HIGH

Incorrect Permission Assignment for Critical Resource (CWE-732)

2023-05-04 cve@mitre.org

RCE Millegpg

7.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

7.8 HIGH

AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Local

Attack Complexity

Low

Privileges Required

Low

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

May 04, 2023 - 02:15 nvd

HIGH 7.8

DescriptionNVD

An issue was discovered in Genomedics MilleGP5 5.9.2, allows remote attackers to execute arbitrary code and gain escalated privileges via modifying specific files.

AnalysisAI

An issue was discovered in Genomedics MilleGP5 5.9.2, allows remote attackers to execute arbitrary code and gain escalated privileges via modifying specific files. Rated high severity (CVSS 7.8), this vulnerability is low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified as Incorrect Permission Assignment (CWE-732), which allows attackers to access resources due to misconfigured permissions. An issue was discovered in Genomedics MilleGP5 5.9.2, allows remote attackers to execute arbitrary code and gain escalated privileges via modifying specific files. Affected products include: Genomedics Millegpg.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Review and restrict file/resource permissions, apply principle of least privilege.